Robert Andrade - Jun 2, 2021 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Signature
/s/ Robert Andrade, Chief Financial Officer
Stock symbol
FENC
Transactions as of
Jun 2, 2021
Transactions value $
$0
Form type
4
Date filed
6/3/2021, 11:58 AM
Next filing
Dec 20, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FENC Stock Option (right to buy) Award $0 +100K $0.00 100K Jun 2, 2021 Common Shares 100K $7.53 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 2, 2021, Robert Andrade was granted an incentive stock option to purchase 100,000 shares of the Issuer's common shares pursuant to the Issuer's 2020 Equity Incentive Plan.
F2 1/3 of the shares subject to this option shall vest immediately and may be exercised as of June 2, 2022 (the "Vesting Commencement Date"). 1/24 of the shares subject to this option shall vest immediately and may be exercised as of the last day of each month following the Vesting Commencement Date. As of May 31, 2024 and thereafter, 100% of the total number of shares subject to this option shall be vested.